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AMONG other specific fields the role of sulphydryl groups in both tumori-
genesis and the developed tumour has received considerable attention. Because
of technical difficulties associated with the measurement of -SH groups within
tissues much of this work has only been via indirect approaches. Recently
Calcutt and Doxey (1959) described a technique which gives quantitative measure-
ments of free -SH groups within tissues. Further application of this technique
during studies with carcinogenic and related agents has led to the hypothesis
that an elevation in the target tissue sulphydryl level is an essential feature of
tumour induction-Calcutt, Doxey and Coates (1961a).
The purpose of the present paper is to summarise the evidence for this hypo-
thesis and to examine the hypothesis in the light of other evidence available in
the literature. It must be stressed that all data and conclusions referred to are
in association with the induction phase of tumours and are not applicable to the
formed tumour.
Evidence for a rise in tissue -SH levels during tumour induction
Measurements of sulphydryl levels fall into three main classes, namely:
measurements of reduced glutathione:
measurements of free tissue -SH plus reduced glutathione:
measurements of free tissue -SH.
Additionally there are in the literature a number ofexamples of measurements
after tissue denaturation, as by homogenisation, grinding procedures, or fixation.
These have been disregarded as not being any approximation to the state of the
normal tissue.
Findings relative to total -SH or glutathione -SH in susceptible tissues treated
with chemical carcinogens in a manner likely to induce tumour formation are
summarised in Table I. In all cases elevations in -SH levels have been recorded
and usually over periods ranging from several weeks to several months. In
limited series of measurements on rat livers treated with N.2-fluoroenylacetamide
or p-dimethyl-aminoazobenzene, Calcutt, Doxey and Coates (1960) found that
rises in total -SH levels were comprised of rises in both protein bound and gluta-
thione -SH.
A number of other records of -SH measurements during tumour induction
also occur in the literature. Crabtree (1946) failed to find any alterations in
the glutathione content of mouse skin after painting with 3,4-benzopyrene or(G. CALCUTT
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1,2: 5,6-dibenzanthracene, but these experiments only extended over a period of
4 hours. With measurements extending over periods of up to five days, Di Paolo
and Niedbala (1957) found elevated mouse skin -SH levels after treatment with
1,2: 5,6-dibenzanthracene or 7,12-dimethylbenzanthracene. Schultze (1960) gave
1-0 ml. of carbon tetrachloride subcutaneously to male rats and nine days later
the livers showed a " significant -SH increase." In an experiment in which kidney
total -SH was measured on hamsters after stilboestrol implants Calcutt et al.
(1960) found high -SH values (at 39 and 74 days after commencement of experi-
ment) in two animals in which the implant had been almost totally absorbed.
The remaining animals showed no sign ofabsorption ofthe implant and -SH levels
were slightly below the control values. Gallico and Boretti (1948) made -SH
measurements onthe livers ofrats receiving o-aminoazotoluene. Estimations were
made at intervals ofseveral months and no allowance was made for the effects of a
restricted diet (rice), so no conclusion can be drawn from these figures.
The evidence so far is weighty but does not exclude the possibility that the
effect is a purely non specific one. In this event it might be anticipated that
chemical carcinogens would display a similar response in tissues which are not
susceptible to the carcinogenic activity of the agent in question. Findings in
this respect have been summarized in Table II. Despite two cases in which slight
TABLE IJ.-Fffects of Carcinogens on Non-taryet Tissue -SH Levels
Period
Effect oni of
Carcinogen Anirnal Tissue -SH observation RefereX e(le
3,4-BenzopYrene Mouse Liver No change 65 days a
3,4-Benzopyrene ,, Kidnev . ,, ,, 6., a
3,4-Benzopyrene Rat Liver Slight decrease 30 . j
1,2: 5,6-Dibenzanthraceei Mouse ,, No change in (10 ,, h
GSH
20-Methvlcholanthrene ,, ,, Ditto 20 ,. /
N.2 Fluoroenvlacetamide Rat Cardiac Slight increase . 104 .,
muscle
J)-Dimethyla,minioazobeizene ,, Kidney No change 76 ,, . a
Urethane Iouse . Skin Decrease 69 ,, a
Stilboestrol Hamster . Liver .. 87 ,, a
o-Arminoazotoluene Aouse Kidney No change 72 ,, C
Carbon tetrachloride, , ,, Slight rise 72 , c
References as in Table I and additionally, j Rondoni and Boretti (1947).
increases in sulphydryl levels have been recorded the overall impression miiust be
that, so far as information is available, chemical carcinogens have little effect on
the -SH level of non-target tissues.
In short term experiments (up to 6 hours) Wrood and Kraynak (1953) found
a fall in the plasma -SH level of dogs which had been injected with 3,4-benzo-
pyrene. This may be merely a reflection of the fall in liver -SH levels which
Calcutt, Doxey and Coates (1959) found to occur temporarily after intravenous
injection of 3,4-benzopyrene into mice.
Another possibility which must be considered is that agents chemically re-
lated to carcinogens would have similar effects to the carcinogens in susceptible
tissues. Here the evidence is very limited. In the case of mouse skin Calcutt
and Coates (1961) have found that repeated paintings with anthracene or pyrene
will induce slight falls in -SH levels or have no effect.G. CALCUTT
The evidence so far, although not conclusive, does favour the view of a rise in
tissue -SH levels in susceptible tissues being associated with carcinogenesis. It
is now necessary to examine some other factors involved in this problem.
Some miscellaneous factors affecting tissue -SH levels
The distribution and availability of sulphydryl groups within tissues is liable
to be influenced by the physiologic state of the animal or tissue in question. It
has been found by Calcutt, Doxey and Coates (1961b) that deletion of riboflavin
from the diet of mice causes a rise in liver -SH levels, whilst the injection of
riboflavin causes a rapid and sustained fall in -SH levels. Deletion of
pantothenate or thiamine from the diet also causes temporary rises in skin -SH
levels (Calcutt, 1961a). A rise in the glutathione content of rabbit muscles can
be brought about by the injection of pituitary growth hormone (Gregory and
Goss, 1934; Goss and Gregory, 1935). In a more recent review, Lazarow (1954)
summarises an extensive literature and shows that hypophysectomy causes a
lowering of glutathione levels in most tissues. Glutathione levels in blood and
tissues are also influenced by adrenal, thyroid, pancreatic and parathyroid
hormones (Lazarow, 1954).
An entirely different class of compounds has also been found, capable of
influencing tissue -SH levels. These are the cocarcinogenic agents. Calcutt
and Coates (1961) have shown that croton oil causes an elevation in mouse skin
total free -SH values for up to five weeks during repeated painting. Oleic acid
also causes an elevation of mouse skin -SH levels (Calcutt, 1961c). An indication
that Tween 60 (polyoxyethylene sorbitan monostearate) which is also cocarcino-
genic behaves in a similar fashion is given by the finding of Setala, Ayrapaa,
Niskanen, Stjernvall and Nyholm (1960) that mouse skin treated with this agent
stains more intensively for -SH groups than does normal skin.
Somefactors enhancing tumourformation and their relation to sulphydryl groups
During the course of experiments devoted to the experimental production of
tumours a number of factors enhancing tumour formation have been elicited.
Tannenbaum (see review by Tannenbaum and Silverstone (1957)), has con-
cluded that overfeeding increases the yield of experimental tumours. The major
action was found to occur during the developmental phase, i.e. the period during
which rises in -SH levels occur (Table I). If the rise in -SH involved extra
cellular requirements for sulphur containing compounds then this could be pro-
vided by the additional feeding ofthe animal during this period. Baumann (1948)
has pointed out that dietary supplements of cystine augment the formation of a
variety of tumours. This again could be the supplying of a basic substrate
required for tissues to develop a high -SH level.
Another factor which enhances tumour development is a diet high in certain
fats. This will influence tumour formation after treatment with p-dimethyl-
aminoazobenzene (Kline, Miller, Rusch and Baumann, 1946), or polycyclic
hydrocarbons (Tannenbaum, 1944). In this latter case it has been shown that
the animals on a high fat diet eat more and thus a high calorie intake is achieved
leading to a situation similar to that considered in the previous paragraph.
Even when allowance is made for this increased calorie intake there is still a
slight augmentation. A possible clue to this effect may lie in the finding by
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Kaunitz, Johnson and Slanetz (1952) that rancid fat can accelerate the utilisation
of riboflavin, an agent known to be protective against certain types of tumour
formation and also able to affect -SH levels (see above).
The best known example of an enhancing factor is the use of croton oil in
skin painting experiments after a minimal dose of carcinogen. Calcutt and
Coates (1961) have shown that after a single application of 7,12-dimethylbenzan-
thracene to mouse skin there is only a transient rise in the skin -SH level and then
a return to the normal level. If this single treatment which would be expected
to yield no-or very few-tumours is followed by repeated paintings with croton
oil then a sustained rise in -SH levels similar to that achieved byrepeated paintings
with dimethylbenzanthracene is achieved. Thus, after an initiating treatment
two different agents, one a carcinogen and the other a non carcinogen, produce
the same biochemical effect and the same biological result.
Anticarcinogens and sulphydryl groups
Considerable attention has been given at various times to the search for agents
which will inhibit the formation of experimental tumours. In a number of cases
specific agents have been used and a clear cut evaluation ofresults is possible, but
in many cases the number of factors involved is such as to make interpretation
difficult if not impossible.
Although never substantiated experimentally the idea that carcinogens became
linked to tissue sulphydryl groups has long been current. On this basis Crabtree
(1944, 1945, 1946) investigated a series ofcompounds known to inhibit sulphydryl
groups or to form mercapturates. These included bromobenzene, maleic and
citraconic anhydrides, anthracene andphenanthrene. When painted on to mouse
skin concurrently with carcinogenic polycyclic hydrocarbons they reduced the
expected tumour yields. It was argued that these compounds reduced the avail-
ability of tissue -SH for binding with the carcinogen. In the light of evidence
considered earlier it can now be suggested that they limit the rise in tissue -SH
level induced by the carcinogen. Further findings which may be considered
similarly are those of Carruthers (1940), Riley and Wallace (1941) and Riley and
Pettigrew (1944), that aldehydes inhibit carcinogenesis since Schubert (1936)
has shown aldehydes to react with thiol compounds. Mustard gas is another
compound which reacts with -SH groups and this was found by Berenbluim (1935)
to inhibit the induction of tar tumours.
On the alternate policy of offering sulphydryl which would compete with that
in the tissue for carcinogens Crabtree (1948) tested a series of monothiols and also
BAL (2: 3 dimercapto-propanol) against tumour induction by polycyclic hydro-
carbons. The monothiols were found to be ineffective but the BAL did show
slight activity. This was confirmation of the experience of Lusky, Braun and
Woodard (1947) who had obtained a noticeable reduction in the yield of benzo-
pyrene induced mouse skin tumours by concurrent treatment with BAL. Earlier,
Reimann and Hall (1936) claimed that thiocresol effectively inhibited carcino-
genesis by 1,2 : 5,6-dibenzanthracene but Crabtree (1948) pointed out that under
the experimental conditions used this conclusion was not warranted. In con-
nection with these experiments a further point derives from the fact that Calcutt
(1949) and Garzia and Dansi (1953) found that benzopyrene was itself oxidised
in the presence of autoxidising thiols. Under these circumstances the applica-
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tion of a thiol to mouse skin already treated with benzopyrene may have resulted
in oxidation of both the carcinogen and thiol and a consequent reduction in the
effective dose of carcinogen.
A rather different type of anticarcinogen is Vitamin A. This was found by
Rosicky and Hatschek (1943) to diminish the yield of mouse skin benzopyrene
tumours when painted concurrently with the carcinogen. It has since been
claimed by Flesch and Goldstone (1952) that Vitamin A inactivates epidermal
-SH groups. Pelc and Fell (1960) have found excess Vitamin A to severely limit
the uptake of cystine throughout the epithelium of chick embryo. This might
indicate a limitation of substrate available for the formation of -SH groups.
Reference has already been made to the general lowering of tissue gluta-
thione levels brought about by hypophysectomy. This procedure has also been
found to profoundly influence the production of experimental tumours. Both
delay in the appearance of a tumour and total suppression of tumour formation
have been recorded. The findings in these experiments have been summarised in
Table III.
TABLE III.-The Influence of Hypophysectomy upon
Experimental Tumour Induction
Agent
3,4-Benzopyrene
Animal
Mouse
3,4-Benzopy-rene . . Rats
20-Methvleholanthrene
9,10-Dimethylbenzanthracene . .
9,10-Dimethylbeiizanthbracene . . .
3'-Methyl, 4-dimethylaminoazobenzene ,,
N.2 Fluoroenyldiacetamide .
* High incidence oftumours of Harderian glai
Site Result Reference
Skin Reduced yield Kortweg and Thomnas
(1939).
Subcut. Delay in Agate, Antopol, Glau-
tissue appearance bach, Agate and
Graff (1955).
Muscle Reduced yield Moon and Simpson
(1955).
Moon, Li and Simpson
(1956).
Delay in Noble and Walters
appearance (1954).
Liver Reduced yield Robertson, O'Neal,
Griffin and Richard-
son (1953).
No tumours* O'Neal, Hoffman,
Dodge and Griffin
(1958).
Human preneoplastic conditions in relation to sulphydryl levels
Gradually it has become recognised that certain human disease states are
associated with a high incidence of tumour occurrence.
A well recognised condition is that oforal leucoplakia, and this has been found
by Abels, Rekers, Martin and Rhoads (1942) to be associated with dietary
insufficiencies of Vitamins A and B2 (riboflavin) and often to respond to improved
diet. Evidence has already been given implicating Vitamin A and B levels with
the sulphydryl content of tissues. It is under conditions of low vitamin levels
that increased -SH levels might beexpected, and in this case there is an association
of low vitamin levels with a precancerous state.
A deficiency of riboflavin has also been associated with the Patterson-Kelly
(Plummer-Vinson) syndrome by Ahlbom (1936). This condition is believed to
predispose to carcinoma of the nasopharynx. Vitamin deficiency has also been
incriminated in the aetiology of liver cancer amongst the Bantus (Berman, 1951).
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Stocks and Karn (1933) concluded that the regular consumption of milk,
green vegetables and possibly wholemeal bread had some kind of protective
influence against cancer. It may not be without point that these foodstuffs are
major sources of riboflavin.
Sulphydryl levels at the end of the latent period
In the earlier part of this paper, evidence was offered that a rise in the target
tissue -SH level occurs during the latent period. This rise was often ofa duration
much shorter than the latent period for the carcinogen and tissue in question.
The question as to what happens to -SH levels up to the appearance ofthe tumour
must be considered. The available evidence is limited. Boyland and Mawson
(1938) continued their glutathione estimations on the livers of mice treated
with 3,4: 5,6-dibenzcarbazole until bile duct proliferation occurred. After 120
days most values had returned to the normal level. Fiala and Fiala (1959) in
their estimations of glutathione in azodye treated rat liver, found that after the
rise period (30-80 days) there was a progressive decline up to 210 days after
initiation of treatment. Although the experiments were not carried on long
enough there are indications in some of the results of Calcutt, Doxey and Coates
(1960, 1961) that after the rise period there is a fall to below normal levels.
There are, additionally, some indications that this reduced -SH level persists
iinto the formed tumour. Thus, Fiala and Fiala (1959) found much lower levels
of glutathione in both azo dye induced hepatomas and the Novikoff hepatoma as
compared with normal rat liver. Kinosita (1938) found primary rat hepatoma
to have a lower glutathione content than rat liver. Greenstein and Leuthardt
(1945) found the total cysteine content of four different rat tumours to be rather
lower than that of normal rat tissues. Doxey (unpublished data) has found azo
dye induced rat hepatoma to have both a lowered glutathione and lowered protein
-SH content as compared with normal rat liver. Benzopyrene induced epithe-
liomata of mouse skin also had a low total -SH content as compared with normal
mouse skin. Several transplantable mouse tumours were also found to have rather
low total -SH values.
Sulphydryl levels in relation to stages ofcarcinogenesis
It is now generally accepted that the carcinogenic process involves at least
two different stages. These are usually referred to as " initiation " and
promotion The datawhich has already been collected must also be considered
in terms of these stages in the carcinogenic process.
Initiation usually only requires a single treatment with the carcinogenic agent.
It was found by Di Paolo and Niedbala (1957) that single applications of 1,2: 5,6-.
dibenzanthracene or 7,12-dimethylbenzanthracene caused temporary -SH rises
in mouse skin -SH levels. Calcutt and Coates (1961) obtained a similar result
with 7,12-dimethylbenzanthracene. Di Paolo and Niedbala (1957) also recorded
slight falls in -SH level shortly after application ofthe hydrocarbons. These may
have been associated with metabolism of the hydrocarbons since Calcutt, Doxey
and Coates (1959) associated similar slight falls in mouse liver -SH values after
treatment with carcinogenic hydrocarbons with detoxication processes. Examina-
tion of the figures in Table I suggests that in many cases there has been no effect
whatever until several applications of the agent have been made. On the basis
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ofthis restricted evidence no conclusions can be drawn as to any immediate effects
upon -SH levels. Calcutt and Coates (1961) have pointed out that prior treat-
ment with dimethylbenzanthracene does appear to affect the timing of a later re-
sponse to croton oil treatment. This however does not necessarily imply an initial
effect upon sulphydryl groups themselves.
When after an initial treatment with a carcinogen further applications of the
same agent or ofcroton oil are made there is a well defined elevation of-SH levels.
This suggests that the main response is during the promotion phase. Whether
the apparent later decline in -SH levels to below normal values should be re-
garded as part of this process or as an independent stage is uncertain.
The whole picture in terms of sulphydrvl levels can be summarised pictorially
as in Fig. 1.
INDTSATONG PROMOTION BY REPEATED DOSES
CARCINOGEN OF CARCINOGEN OR COCARCINOGEN ~~~~I I
< ....~~~~~~....... ..........
TISSUE
Ul ~ ~ ~ . .. . .... .. ............ ...
z
cc ~~~~~~~~~~~~TUMOUR
Lu
LATENT PERIOD ..........
TI ME
FIG. 1.-Changes in tissue sulphydryl levels durinig carciniogenesis by chemical agents.
GENERAL DISCU*SSION
The evidence which has been quoted above offers a reasonable basis for the
overall picture of the behaviour of tissue -SR groups during the carcinogenic
process. That there is a direct association between the carcinogenic process and
-SR levels is attested by the target tissue specificity of the response to carcinogens
and the inhibitory effect of known -SR inhibitors uipon the carcinogenic response..
Whether the actual tissue sulphydryl content is directly involved in carcinogenesis,
or whether the -SR level is merely symptomatic of some other more essential
tissue change is unknown. Certainly it seems very unlikely that -SR levels could
be altered without concomitant changes in enzymatic and other cellular activities.
The -SR measurements, however, do offer a direct estimate of the biochemicalSULPHYDRYL GROUPS AND TUMOUR INDUCTION 681
status of the tissue from the time of initiation through to the emergence of the
developed tumour, and as such offer considerable scope for the further assessment
of factors influencing carcinogenesis.
Evidence for the origin of the -SH groups which appear in tissues during the
early stages of treatment with carcinogenic chemicals or cocarcinogens is lacking.
Again the question as to what happens to this material during the later stages
of carcinogenesis still requires an answer.
This paper has collected together data from many and varied sources. Much
of this information is superficially unrelated but on the basis of involvement with
sulphydryl levels a unifying factor is apparent. The original hypothesis that an
elevated sulphydryl level in the target tissue is an essential for tumorigenesis has
been found consistent with other data in the literature. At the same time it is
suggested that a more complete picture would be one of elevation of tissue -SH
levels followed by a fall to subnormal values and the persistence ofthis latter value
into the formed tumour.
No excuse is offered for this paper being speculative in parts ; it is merely
hoped that this will help to stimulate further experimental work and the publica-
tion of data which will help to confirm or refute the ideas which have been
expressed.
SUMMARY
1. The evidence for chemical carcinogens causing a rise in target tissue
sulphydryl levels has been summarised.
2. It has been shown that many agents or factors promoting or inhibiting
carcinogenesis can affect tissue -SH levels in a manner which is predictable on the
hypothesis that elevated tissue -SH is an essential part ofthe carcinogenic process.
3. It is concluded that during carcinogenesis a period of elevated tissue -SH
occurs and is followed by a period of subnormal levels. This latter subnormal
level is persistent into the resultant tumour.
4. Influence upon sulphydryl levels is a unifying factor which connects much
apparently unrelated experimental data.
I am indebted to Mr. D. Doxey of this Department, for permission to quote
from his umpublished experimental results.
The expenses of this work were defrayed from a block grant from The British
Empire Cancer Campaign.
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